These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37985627)

  • 1. Assessing the impact of different heparin dosing regimens for cardiopulmonary bypass on anticoagulation: the HepDOSE pilot study.
    Lwin TN; Mudannayake R; MacDonald S; Arrowsmith JE; Burt C; Besser M; Falter F
    Can J Anaesth; 2024 Feb; 71(2):234-243. PubMed ID: 37985627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
    Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
    PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
    Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
    Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased accuracy in heparin and protamine administration decreases bleeding: a pilot study.
    Runge M; Møller CH; Steinbrüchel DA
    J Extra Corpor Technol; 2009 Mar; 41(1):10-4. PubMed ID: 19361026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
    Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
    Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
    Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum protamine dose required to neutralize heparin in cardiac surgery: a single-centre, prospective, observational cohort study.
    Taneja R; Szoke DJ; Hynes Z; Jones PM
    Can J Anaesth; 2023 Feb; 70(2):219-227. PubMed ID: 36471142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery-Results of a Randomized Controlled Trial.
    Lax M; Pesonen E; Hiippala S; Schramko A; Lassila R; Raivio P
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2362-2368. PubMed ID: 32127275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine dosing and its impact in cardiac surgery transfusion practice-A retrospective bi-institutional analysis.
    Mondal S; Abuelkasem E; Vesselinov R; Henderson R; Choi S; Mousa A; Zaza KJ; Tanaka KA
    Transfusion; 2024 Mar; 64(3):467-474. PubMed ID: 38264767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.